{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:30:42Z","timestamp":1765960242886,"version":"3.37.3"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Recurrent pleural effusions are a major cause of morbidity and frequently lead to hospitalization. Indwelling pleural catheters (IPCs) are tunneled catheters that allow ambulatory intermittent drainage of pleural fluid without repeated thoracentesis. Despite the efficacy and safety of IPCs, data supporting postplacement follow-up is limited and variable. Our study aims to characterize the impact of a dedicated pleural clinic (PC) on patient outcomes as they relate to IPCs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients who underwent IPC placement between 2015 and 2021 were included in this retrospective study. Differences in outcomes were analyzed between patients with an IPC placed and managed by Interventional Pulmonology (IP) through the PC and those placed by non-IP services (non-PC providers) before and after the PC implementation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 371 patients received IPCs. Since the implementation of the PC, there was an increase in ambulatory IPC placement (31\/133 pre-PC vs. 96\/238 post-PC; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001). There were fewer admissions before IPC placement (18\/103 vs. 43\/133; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.01), and fewer thoracenteses per patient (2.7\u00b12.5 in PC cohort vs. 4\u00b15.1 in non-PC cohort; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01). The frequency of pleurodesis was higher in the PC cohort (40\/103 vs. 41\/268; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). A Fine and Gray competing risks model indicated higher likelihood of pleurodesis in the PC cohort (adjusted subhazard ratio 3.8, 95% CI: 2.5-5.87).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our experience suggests that the implementation of a dedicated PC can lead to improved patient outcomes including fewer procedures and admissions before IPC placement, and increased rates of pleurodesis with IPC removal.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/lbr.0000000000000901","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T04:01:25Z","timestamp":1664856085000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Impact of a Dedicated Pleural Clinic on Indwelling Pleural Catheter Related Outcomes"],"prefix":"10.1097","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-0809","authenticated-orcid":false,"given":"Katherine B.","family":"Malcolm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaron B.","family":"Gesthalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"R1-20240809","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.mcna.2011.08.005","article-title":"Pleural effusions","volume":"95","author":"Light","year":"2011","journal-title":"Med Clin North Am"},{"key":"R2-20240809","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.chest.2020.05.594","article-title":"Management of indwelling tunneled pleural catheters: a modified delphi consensus statement","volume":"158","author":"Gilbert","year":"2020","journal-title":"Chest"},{"key":"R3-20240809","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(15)00183-6","article-title":"Individualised management of malignant pleural effusion","volume":"3","author":"Clive","year":"2015","journal-title":"Lancet Respir Med"},{"key":"R4-20240809","first-page":"329","article-title":"The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation","volume":"36","author":"DiBonito","year":"1992","journal-title":"Acta Cytol"},{"key":"R5-20240809","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"4","author":"Dipper","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20240809","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.21037\/jtd.2018.04.160","article-title":"Indwelling pleural catheters: complications and management strategies","volume":"10","author":"Chalhoub","year":"2018","journal-title":"J Thorac Dis"},{"key":"R7-20240809","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"key":"R8-20240809","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1183\/16000617.0026-2016","article-title":"The management of benign non-infective pleural effusions","volume":"25","author":"Bintcliffe","year":"2016","journal-title":"Eur Respir Rev"},{"key":"R9-20240809","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/1097-0142(19911001)68:7<1495::AID-CNCR2820680705>3.0.CO;2-6","article-title":"A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer","volume":"68","author":"Masuno","year":"1991","journal-title":"Cancer"},{"key":"R10-20240809","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1164\/rccm.201704-0809OC","article-title":"Randomized controlled trial of urokinase versus placebo for nondraining malignant pleural effusion","volume":"197","author":"Mishra","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"2B","key":"R11-20240809","first-page":"1495","article-title":"Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer","volume":"26","author":"Kasahara","year":"2006","journal-title":"Anticancer Res"},{"key":"R12-20240809","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1378\/chest.117.1.73","article-title":"Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease","volume":"117","author":"Burrows","year":"2000","journal-title":"Chest"},{"key":"R13-20240809","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.00217114","article-title":"Mortality among patients with pleural effusion undergoing thoracentesis","volume":"46","author":"DeBiasi","year":"2015","journal-title":"Eur Respir J"},{"key":"R14-20240809","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"Putnam","year":"1999","journal-title":"Cancer"},{"key":"R17-20240809","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"issue":"suppl 2)","key":"R18-20240809","first-page":"ii32","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"R19-20240809","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review","volume":"26","author":"Van Meter","year":"2011","journal-title":"J Gen Intern Med"},{"key":"R20-20240809","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.chest.2016.10.052","article-title":"Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis","volume":"151","author":"Patil","year":"2017","journal-title":"Chest"},{"key":"R21-20240809","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0003-4975(99)01482-4","article-title":"Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter","volume":"69","author":"Putnam","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R22-20240809","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1378\/chest.13-0331","article-title":"Use of indwelling pleural catheters for cardiogenic pleural effusions","volume":"144","author":"Srour","year":"2013","journal-title":"Chest"},{"key":"R23-20240809","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1753465814565353","article-title":"Indwelling pleural catheters for pleural effusions associated with end-stage renal disease: a case series","volume":"9","author":"Potechin","year":"2015","journal-title":"Ther Adv Respir Dis"},{"key":"R24-20240809","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.athoracsur.2014.02.027","article-title":"A propensity-matched comparison of pleurodesis or tunneled pleural catheter for heart failure patients with recurrent pleural effusion","volume":"97","author":"Freeman","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"R25-20240809","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/LBR.0000000000000707","article-title":"AABIP evidence-informed guidelines and expert panel report for the management of indwelling pleural catheters","volume":"27","author":"Miller","year":"2020","journal-title":"J Bronchol Interv Pulmonol"},{"key":"R26-20240809","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the ample randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"key":"R27-20240809","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R28-20240809","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R29-20240809","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. an official ats\/sts\/str clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R30-20240809","doi-asserted-by":"crossref","first-page":"P20","DOI":"10.1164\/rccm.20011P20","article-title":"Indwelling Tunneled Pleural Catheters","volume":"200","author":"Kheir","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-20240809","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1440-1843.2010.01832.x","article-title":"Setting up a specialist pleural disease service","volume":"15","author":"Hooper","year":"2010","journal-title":"Respirology"},{"key":"R32-20240809","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.arbr.2020.02.001","article-title":"Clinical impact of a pleural unit in a tertiary level hospital. [Impacto cl\u00ednico de una unidad de patolog\u00eda pleural en un hospital de tercer nivel]","volume":"56","author":"Enr\u00edquez Rodr\u00edguez","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"R33-20240809","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.arbres.2010.05.010","article-title":"Estudio de coste-efectividad del manejo diagn\u00f3stico del derrame pleural en una unidad de patolog\u00eda pleural ambulatoria [Cost-effectiveness study of the diagnosis of pleural effusion in chest diseases outpatient clinic]","volume":"46","author":"Botana Rial","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"R35-20240809","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.chest.2017.08.026","article-title":"Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions","volume":"153","author":"Ost","year":"2018","journal-title":"Chest"},{"key":"R36-20240809","doi-asserted-by":"crossref","first-page":"2101362","DOI":"10.1183\/13993003.01362-2021","article-title":"Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions","volume":"59","author":"Walker","year":"2022","journal-title":"Eur Respir J"},{"key":"R37-20240809","doi-asserted-by":"crossref","first-page":"h4520","DOI":"10.1136\/bmj.h4520","article-title":"The modern diagnosis and management of pleural effusions","volume":"351","author":"Bhatnagar","year":"2015","journal-title":"BMJ"},{"key":"R38-20240809","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Journal of Bronchology &amp; Interventional Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:25:17Z","timestamp":1723217117000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000901"}},"subtitle":["A Retrospective Single Center Experience"],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/lbr.0000000000000901","relation":{},"ISSN":["1948-8270"],"issn-type":[{"type":"electronic","value":"1948-8270"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"2022-05-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}